These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22039292)

  • 1. The radioprotection management of a PET department with a cyclotron and radiopharmacy laboratory, in accordance with Italian legislation.
    Russo AA; Ferrari P; Casale M; Delia R
    Radiat Prot Dosimetry; 2011 Sep; 147(1-2):240-6. PubMed ID: 22039292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities.
    Zanzonico P; Dauer L; St Germain J
    Health Phys; 2008 Nov; 95(5):554-70. PubMed ID: 18849690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation dose management in CT, SPECT/CT and PET/CT techniques.
    Mattsson S; Söderberg M
    Radiat Prot Dosimetry; 2011 Sep; 147(1-2):13-21. PubMed ID: 21725080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation exposure of patients and personnel from a PET/CT procedure with 18F-FDG.
    Leide-Svegborn S
    Radiat Prot Dosimetry; 2010; 139(1-3):208-13. PubMed ID: 20167792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standardization of quantitative imaging: the time is right, and 18F-FDG PET/CT is a good place to start.
    Buckler AJ; Boellaard R
    J Nucl Med; 2011 Feb; 52(2):171-2. PubMed ID: 21233179
    [No Abstract]   [Full Text] [Related]  

  • 6. Variations in clinical PET/CT operations: results of an international survey of active PET/CT users.
    Beyer T; Czernin J; Freudenberg LS
    J Nucl Med; 2011 Feb; 52(2):303-10. PubMed ID: 21233186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personal radiation doses in PET/CT facility: measurements vs. calculations.
    Hippeläinen E; Nikkinen P; Ihalainen T; Uusi-Simola J; Savolainen S
    Radiat Prot Dosimetry; 2008; 132(1):57-63. PubMed ID: 18713782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical aspects of radiation safety for using fluorine-18.
    Bixler A; Springer G; Lovas R
    J Nucl Med Technol; 1999 Mar; 27(1):14-6; quiz 18-9. PubMed ID: 10322569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography: a first-hand experience.
    Traylor J
    Radiol Manage; 2000; 22(1):41-7. PubMed ID: 10787761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation safety with positron emission tomography and computed tomography.
    Devine CE; Mawlawi O
    Semin Ultrasound CT MR; 2010 Feb; 31(1):39-45. PubMed ID: 20102694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A brief review of Japanese guidelines for the clinical use of (18)F-FDG-PET/MRI 2012 (Ver 1.0).
    Kaneta T
    Ann Nucl Med; 2013 May; 27(4):309-13. PubMed ID: 23508379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET/CT examinations.
    Brix G; Lechel U; Glatting G; Ziegler SI; Münzing W; Müller SP; Beyer T
    J Nucl Med; 2005 Apr; 46(4):608-13. PubMed ID: 15809483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [PET and diagnostic technology evaluation in a global clinical process. DGN's point of view].
    Kotzerke J; Dietlein M; Grünwald F; Bockisch A
    Nuklearmedizin; 2010; 49(1):6-12. PubMed ID: 20087534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technologist radiation exposure in routine clinical practice with 18F-FDG PET.
    Guillet B; Quentin P; Waultier S; Bourrelly M; Pisano P; Mundler O
    J Nucl Med Technol; 2005 Sep; 33(3):175-9. PubMed ID: 16145226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is hybridic positron emission tomography/computerized tomography the only option? The future of nuclear medicine and molecular imaging.
    Grammaticos P; Zerva C; Asteriadis I; Trontzos C; Hatziioannou K
    Hell J Nucl Med; 2007; 10(2):74-6. PubMed ID: 17684579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation dose to PET technologists and strategies to lower occupational exposure.
    Roberts FO; Gunawardana DH; Pathmaraj K; Wallace A; U PL; Mi T; Berlangieri SU; O'Keefe GJ; Rowe CC; Scott AM
    J Nucl Med Technol; 2005 Mar; 33(1):44-7. PubMed ID: 15731021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of FDG-PET/CT imaging in head and neck malignant conditions: impact on diagnostic accuracy and patient care.
    Gordin A; Golz A; Keidar Z; Daitzchman M; Bar-Shalom R; Israel O
    Otolaryngol Head Neck Surg; 2007 Jul; 137(1):130-7. PubMed ID: 17599580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET and PET-CT in radiation treatment planning for lung cancer.
    Aristei C; Falcinelli L; Palumbo B; Tarducci R
    Expert Rev Anticancer Ther; 2010 Apr; 10(4):571-84. PubMed ID: 20397922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement and control of the air contamination generated in a medical cyclotron facility for PET radiopharmaceuticals.
    Calandrino R; del Vecchio A; Todde S; Fazio F
    Health Phys; 2007 May; 92(5 Suppl):S70-7. PubMed ID: 17440326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-standard radionuclide production for PET in Japan.
    Fujibayashi Y; Suzuki K; Fukumura T; Mori T; Kasamatsu S
    Q J Nucl Med Mol Imaging; 2008 Jun; 52(2):140-4. PubMed ID: 18043540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.